Insider Holders & Insider Ownership - Cyclacel Pharmaceuticals Inc. (CYCC)

List of insiders holdings for Cyclacel Pharmaceuticals Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
MARXE AUSTIN W & GREENHOUSE DAVID M
10% Owner
2011-11-09 09:02:132,847,448
0
2,847,448Form 13G
MPM BIOVENTURES II QP LP
MPM BIOVENTURES II LP
MPM BIOVENTURES II GMBH & CO PARALLEL BETEILIGUNGS KG
MPM ASSET MANAGEMENT INVESTORS 2000B LLC
GADICKE ANSBERT
EVNIN LUKE
GALAKATOS NICHOLAS
STEINMETZ MICHAEL
WHEELER KURT
10% Owner
2005-02-10 17:18:281,180,965
0
1,180,965Form 13G
DELEAGE JEAN
NOHRA GUY P
ALTA CALIFORNIA PARTNERS LP
ALTA EMBARCADERO PARTNERS LLC
GRUENER GARRETT
ALTA CALIFORNIA MANAGEMENT PARTNERS LP
Director
2004-03-24 21:04:595455
1,142,400
1,147,855Form 4/A
CURRY ROBERT E
Director
2004-03-23 20:28:480
960,964
960,964Form 4
LAZARUS STEVEN
10% Owner
2004-11-02 17:51:490
851,060
851,060Form 4
ARCH VENTURE PARTNERS V LP
10% Owner
2004-11-02 16:48:270
851,060
851,060Form 4
ARCH V ENTREPRENEURS FUND LP
10% Owner
2004-11-02 16:29:595698
845,362
851,060Form 4
ARCH VENTURE FUND III L P
10% Owner
2004-11-02 16:57:310
851,060
851,060Form 4
BYBEE CLINTON
10% Owner
2004-11-02 17:39:090
851,060
851,060Form 4
CRANDELL KEITH
10% Owner
2004-11-02 17:39:310
851,060
851,060Form 4
ARCH MANAGEMENT PARTNERS II LP
ARCH VENTURE PARTNERS LP
ARCH VENTURE CORP
10% Owner
2004-11-02 16:58:500
851,060
851,060Form 4
ARCH VENTURE FUND II LP
10% Owner
2004-11-02 16:14:390
851,060
851,060Form 4
HEALTHCARE FOCUS FUND LP
10% Owner
2004-11-02 16:39:330
851,060
851,060Form 4
ARCH VENTURE PARTNERS LLC
10% Owner
2004-11-02 17:15:300
851,060
851,060Form 4
Flynn James E
DEERFIELD CAPITAL LP
Deerfield Special Situations Fund L.P.
DEERFIELD MANAGEMENT CO
Deerfield Special Situations Fund International LTD
Possible Member of 10% Group
10% Owner
2009-02-13 16:24:27491,072
0
491,072Form 13G
DELEAGE JEAN
ALTA PARTNERS
ALTA CALIFORNIA PARTNERS LP
ALTA CALIFORNIA MANAGEMENT PARTNERS LP
ALTA EMBARCADERO PARTNERS II LLC
GRUENER GARRETT
NOHRA GUY P
Director
10% Owner
2006-12-08 17:05:10425,529
0
425,529Form 13G
TANG KEVIN C
TANG CAPITAL MANAGEMENT LLC
TANG CAPITAL PARTNERS LP
10% Owner
2017-11-22 17:00:16336,747
0
336,747Form 13D
Eastern Capital LTD
Portfolio Services Ltd.
DART KENNETH BRYAN
10% Owner
2020-05-05 17:23:09108,363
0
108,363Form 13G
BERENSON RONALD J
President and CEO
2005-02-07 20:58:47100,000
0
100,000Form 4
Ferguson Kenneth M.
Director
2023-07-03 16:56:1287,390
0
87,390Form 4
Walker Karin L
Director
2023-07-03 16:56:3383,040
0
83,040Form 4
BARKER SAM L
Director
2023-07-03 16:57:5482,853
0
82,853Form 4
HENNEY CHRISTOPHER S
Director
2023-07-03 16:55:4581,853
0
81,853Form 4
Spiegel Robert J.
Director
2023-07-03 16:57:3381,853
0
81,853Form 4
Rombotis Spiro George
President and CEO
2023-12-26 16:05:2374,728
0
74,728Form 4
Kirschbaum Mark
Chief Medical Officer
2023-07-03 16:56:5270,200
0
70,200Form 4
Womelsdorf Dr John Francis
VP, Business Development
2008-11-20 18:58:5966,700
0
66,700Form 4
Jackson Robert
S.V.P. & Chief Scientific Offi
2006-07-11 16:15:0063,606
0
63,606Form 4
Westwood Robert
V.P., Chem. & Preclin. Dev.
2006-12-26 15:24:1650,000
0
50,000Form 4
Sems Lloyd
Director
2022-06-16 16:11:5349,841
0
49,841Form 4
CRAIG STEWART
COO and VP
2005-02-07 20:59:0140,000
0
40,000Form 4
KIRKMAN ROBERT L
Chief Business Officer and VP
2005-02-07 20:59:0440,000
0
40,000Form 4
LANGECKER PETER
Director
2005-06-17 16:45:0237,500
0
37,500Form 4
McBarron Paul
See Remarks
2023-12-26 16:05:2535,264
0
35,264Form 4
Legault Pierre
Director
2008-02-21 09:01:0235,000
0
35,000Form 4
SPIEGELMAN DANIEL K
Director
2012-05-24 21:31:1535,000
0
35,000Form 4
Reyes Gregory
Senior VP, Research
2008-03-21 10:18:0128,000
0
28,000Form 4
Sosnowski Robert Edward
VP, Marketing & Sales
2011-12-08 18:34:3828,000
0
28,000Form 4
SCHWARTZ BRIAN
Interim Chief Medical Officer
2024-01-31 16:56:0127,705
0
27,705Form 4
McVie John Gordon
Director
2008-02-21 08:58:2125,000
0
25,000Form 4
BONYHADI MARK L
Vice President, Research
2005-02-07 20:58:5225,000
0
25,000Form 4
WERTHEIMER STEPHEN
Director
2005-06-17 16:45:2322,500
0
22,500Form 4
Chiao Judy
V.P., Clin. Dev. & Reg. Aff.
2019-12-09 21:01:3121,249
0
21,249Form 4
FROHLICH MARK
Medical Director and VP
2005-02-07 20:58:5920,000
0
20,000Form 4
CORDOVA L KATHI
SVP Finance, Treasurer
2005-02-07 20:58:5520,000
0
20,000Form 4
Bacopoulos Nicholas G
Director
2016-05-31 16:30:2915,000
0
15,000Form 4
BLACK JOANNA S
VP and General Counsel, Secret
2005-02-07 20:58:5512,500
0
12,500Form 4
NELSEN ROBERT
Director
10% Owner
2005-06-17 18:19:5110000
0
10000Form 4
Collins William
General Manager
2008-04-07 20:02:4510000
0
10000Form 4/A
WILLIAMS ROBERT MICHAEL
Director
2005-06-17 16:46:3510000
0
10000Form 4
Hradsky Gregory T.
Director
2021-06-17 16:09:127122
0
7122Form 4
Banham John Michael Middlecott
Director
2020-06-29 18:51:065200
0
5200Form 4
UPRICHARD DAVID C
Director
2020-06-29 18:49:215200
0
5200Form 4
Romel Lawrence A
VP Clinical Operations
2005-02-07 20:59:045000
0
5000Form 4
HIGHBRIDGE CAPITAL CORP
HIGHBRIDGE CAPITAL MANAGEMENT LLC
Dubin Glenn
Swieca Henry
Highbridge International LLC
10% Owner
2006-02-13 16:36:42187
0
187Form 13G
HENNER DENNIS
Director
2004-03-10 15:57:390
0
0Form 3
DELEAGE JEAN
Nolonger Director or 10% Owner
Director
2006-12-04 15:56:410
0
0Form 4
MORGAN STANLEY
10% Owner
2010-12-10 09:41:230
0
0Form 13G
ARCH VENTURE FUND V LP
10% Owner
2006-04-13 16:27:450
0
0Form 13D
CREDIT SUISSE FIRST BOSTON
10% Owner
2006-02-14 17:04:470
0
0Form 13G